当前位置:首页 - 行情中心 - 新芝生物(920685) - 财务分析 - 现金流量表

新芝生物

(920685)

  

流通市值:8.63亿  总市值:14.41亿
流通股本:5477.86万   总股本:9151.60万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金133,398,690.5182,328,815.938,111,475.59190,015,716.45
  收到的税费返还1,970,048.131,619,065.231,075,771.393,581,243.38
  收到其他与经营活动有关的现金4,683,207.082,917,053.451,292,527.968,300,947.03
  经营活动现金流入小计140,051,945.7286,864,934.5840,479,774.94201,897,906.86
  购买商品、接受劳务支付的现金37,664,847.9220,757,146.528,456,537.0251,214,596.96
  支付给职工以及为职工支付的现金50,896,226.1537,702,266.4425,606,348.6164,748,600.1
  支付的各项税费17,136,386.5313,785,611.347,991,223.5217,341,925.59
  支付其他与经营活动有关的现金11,813,232.078,501,207.84,182,447.4417,587,991.09
  经营活动现金流出小计117,510,692.6780,746,232.146,236,556.59150,893,113.74
  经营活动产生的现金流量净额22,541,253.056,118,702.48-5,756,781.6551,004,793.12
二、投资活动产生的现金流量:
  收回投资收到的现金820,450,400.4628,450,400.4283,774,753.8914,000,000
  取得投资收益收到的现金3,227,916.141,965,565.021,083,988.595,583,381.41
  处置固定资产、无形资产和其他长期资产收回的现金净额190,000190,000190,00022,571,655.2
  投资活动现金流入小计823,868,316.54630,605,965.42285,048,742.39942,155,036.61
  购建固定资产、无形资产和其他长期资产支付的现金26,881,902.4223,281,930.8411,468,955.6569,834,244.59
  投资支付的现金810,966,918.94603,297,107.74218,642,069.38909,000,000
  取得子公司及其他营业单位支付的现金---5,804,750.06
  投资活动现金流出小计837,848,821.36626,579,038.58230,111,025.03984,638,994.65
  投资活动产生的现金流量净额-13,980,504.824,026,926.8454,937,717.36-42,483,958.04
三、筹资活动产生的现金流量:
  吸收投资收到的现金---850,000
  其中:子公司吸收少数股东投资收到的现金---850,000
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---850,000
  分配股利、利润或偿付利息支付的现金25,045,746.7125,045,746.719,047,619.0535,551,394.8
  其中:子公司支付给少数股东的股利、利润--9,047,619.05-
  支付其他与筹资活动有关的现金2,092,705.411,300,587.96482,278.475,905,350.44
  筹资活动现金流出小计27,138,452.1226,346,334.679,529,897.5241,456,745.24
  筹资活动产生的现金流量净额-27,138,452.12-26,346,334.67-9,529,897.52-40,606,745.24
四、汇率变动对现金及现金等价物的影响-20,443.69-938.56-4,046.18-62,427.74
五、现金及现金等价物净增加额-18,598,147.58-16,201,643.9139,646,992.01-32,148,337.9
  加:期初现金及现金等价物余额95,439,922.8895,439,922.8895,439,922.88127,588,260.78
  期末现金及现金等价物余额76,841,775.379,238,278.97135,086,914.8995,439,922.88
补充资料:
  净利润-15,144,602.06-51,647,030.17
  资产减值准备-1,298,986.72-1,804,158.47
  固定资产和投资性房地产折旧-2,162,171.32-4,916,301.93
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-2,162,171.32-4,916,301.93
  无形资产摊销-302,705.92-772,759.28
  长期待摊费用摊销-513,902.35-1,118,853.59
  处置固定资产、无形资产和其他长期资产的损失----13,680,415.14
  固定资产报废损失---11,972.2
  公允价值变动损失--1,598,663.34--3,163,765.13
  财务费用-37,949.43-248,672.16
  投资损失--1,125,535.31--2,752,930.97
  递延所得税-111,122.34-1,302,129.37
  其中:递延所得税资产减少-118,925.42-1,303,528.37
    递延所得税负债增加--7,803.08--1,399
  存货的减少--4,721,905.06-4,753,428.73
  经营性应收项目的减少-4,219,542.34--5,296,102.05
  经营性应付项目的增加--11,638,030.14-4,375,983.64
  其他--224,648.43-1,323,650
  不涉及现金收支的投资和筹资活动金额其他项目---0
  现金的期末余额-79,238,278.97-95,439,922.88
  减:现金的期初余额-95,439,922.88-127,588,260.78
  现金及现金等价物的净增加额--16,201,643.91--32,148,337.9
公告日期2025-10-292025-08-262025-04-282025-04-21
审计意见(境内)标准无保留意见
TOP↑